Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease Margien L. Seinen, Cyriel Y. Ponsioen, Nanne K.H. de Boer, Bas Oldenburg, Gerd Bouma, Chris J.J. Mulder, Adriaan A. van Bodegraven Clinical Gastroenterology and Hepatology Volume 11, Issue 6, Pages 667-672 (June 2013) DOI: 10.1016/j.cgh.2012.12.026 Copyright © 2013 AGA Institute Terms and Conditions
Figure 1 Flow chart of all CD patients screened and followed up throughout the study. Clinical Gastroenterology and Hepatology 2013 11, 667-672DOI: (10.1016/j.cgh.2012.12.026) Copyright © 2013 AGA Institute Terms and Conditions
Figure 2 Kaplan–Meier curve (including 95% CI interval) regarding sustained clinical benefit of monotherapy MTX in CD patients. Clinical Gastroenterology and Hepatology 2013 11, 667-672DOI: (10.1016/j.cgh.2012.12.026) Copyright © 2013 AGA Institute Terms and Conditions